Furthermore, we found that trametinib partially restrained the up-regulation of ERRα induced by EGF exposure, and the inhibition of ERRα increased the sensitivity of colon cancer cells to trametinib. This evidence concerns the gene ESRRA and malignant colon neoplasm.